RxDoctor Payments Data

Jalaja Piska, MD

Anesthesiology · Frankfort, ILNPI 1427035815

Payments from drug & device makers

$4,276in general payments, 2019–2025

Across 218 payments — averaging $19.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$918
  • Nalu Medical, Inc.$473
  • Collegium Pharmaceutical, Inc.$467
  • Abbott$309
  • Si-bone, Inc.$257
  • Amgen$210
  • plus $2K from 27 others

What the payments were for

  • Travel & lodging$1654%
  • Food & beverage$4,10496%
  • Education$70%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,276 in reported general payments places this provider in the 90th percentile of 1,980 anesthesiology providers in Illinois.

See all anesthesiology providers in Illinois

Medicare billing

Part B allowed, 2024
$145,113
Medicare patients
202
Services billed
5,496

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen815$24,989
Xtampza ErOxycodone Myristate15$15,432
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen275$9,291
Pregabalin97$4,565
Gabapentin142$2,730
Fentanyl16$1,519
Oxycodone Hcl45$1,429
Celecoxib23$1,384
Lidocaine12$1,075
Tizanidine Hcl139$1,015
Cyclobenzaprine Hcl110$849
Tramadol Hcl ErTramadol Hcl17$849
Tramadol Hcl70$610
Baclofen19$589
Hydromorphone Hcl35$560

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er$467$15,43215 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,980 anesthesiology providers in Illinois.

Other anesthesiology in Frankfort

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →